Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study

BACKGROUND: Ipilimumab has shown long-term overall survival (OS) in patients with advanced melanoma in clinical trials, but robust real-world evidence is lacking. We present long-term outcomes from the IMAGE study (NCT01511913) in patients receiving ipilimumab and/or non-ipilimumab (any approved tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalle, Stéphane, Mortier, Laurent, Corrie, Pippa, Lotem, Michal, Board, Ruth, Arance, Ana María, Meiss, Frank, Terheyden, Patrick, Gutzmer, Ralf, Buysse, Brian, Oh, Kelly, Brokaw, Jane, Le, T. Kim, Mathias, Susan D., Scotto, Julie, Lord-Bessen, Jennifer, Moshyk, Andriy, Kotapati, Srividya, Middleton, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164785/
https://www.ncbi.nlm.nih.gov/pubmed/34051732
http://dx.doi.org/10.1186/s12885-021-08032-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8164785/
https://www.ncbi.nlm.nih.gov/pubmed/34051732
http://dx.doi.org/10.1186/s12885-021-08032-y

Ejemplares similares